Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV)…
Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…
Survey of 1,340 HR leaders shows widespread AI use, prioritizing solutions that value employee trustSAN FRANCISCO--(BUSINESS WIRE)--#HealthWayFinding--Transcarent, the One Place…
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common…
SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- Global consulting firm J.S. Held announces a collaboration between the International Valuation Standards Council (IVSC),…
Study of 300+ executives identifies misalignment between marketing and IT as key barrier to AI transformation CHICAGO, Sept. 10, 2025…
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
September 06, 2025 14:30 ET | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…